CN Patent

CN101557706B — 雷沙吉兰碱结晶固体

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2013-08-07 · 13y expired

What this patent protects

本发明提供R(+)-N-炔丙基-1-氨基茚满结晶、可药用组合物及其制备方法。

USPTO Abstract

本发明提供R(+)-N-炔丙基-1-氨基茚满结晶、可药用组合物及其制备方法。

Drugs covered by this patent

rasagiline-mesylate (RASAGILINE MESYLATE)

Patent Metadata

Patent number: CN101557706B
Jurisdiction: CN
Classification: —
Expires: 2013-08-07
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.